|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-20
|
|
pubmed:abstractText |
Adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are a frequently reported problem due to the fact that these molecules are often used for control of pain and inflammation. Although the use of selective inhibitors of cyclooxygenase (COX) 2 helps to prevent some of these adverse reactions, they can have cardiac side effects when taken for prolonged periods. Here we report the safety and tolerability of etoricoxib, a selective COX-2 inhibitor with fewer cardiovascular effects, in patients with adverse reactions to NSAIDs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-9068
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
163-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18564626-Administration, Oral,
pubmed-meshheading:18564626-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:18564626-Cyclooxygenase 2,
pubmed-meshheading:18564626-Cyclooxygenase Inhibitors,
pubmed-meshheading:18564626-Female,
pubmed-meshheading:18564626-Humans,
pubmed-meshheading:18564626-Male,
pubmed-meshheading:18564626-Middle Aged,
pubmed-meshheading:18564626-Pyridines,
pubmed-meshheading:18564626-Sulfones
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Safety of etoricoxib in patients with reactions to NSAIDs.
|
|
pubmed:affiliation |
Allergology High Specialty Unit, General Medicine, Faenza Hospital, AUSL Ravenna, Italy. fa.allergologia@ausl.ra.it
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
